2020•Al-Azhar International Medical Journal /Al-Azhar International Medical JournalOpen access

Laboratory Evaluation for Mitochondrial Dysfunction in Multiple Sclerosis Patients

Kamel Mahmoud Hewedi, Ahmed Abd El Aziz, Ahmed Essmat, Mohammed Faheem

Open full text 2 citations

Abstract

Background and aim: It’s though that mitochondrial dysfunction is participated in multiple sclerosis (MS) pathogenesis. Serum lactate and uric acid levels are biochemical markers related to mitochondrial dysfunction. The present study aimed to assess mitochondrial dysfunction in sufferers with MS through investigating lactate and uric acid serum levels. Subjects and methods: This case manages observe turned into carried out on 32 patients with MS and 20 safe controls matched by age and sex. Patients have been diagnosed with MS in keeping with Revised McDonald Criteria. Both participants underwent a careful history taking, thorough general and neurological exam and evaluation of serum lactate and uric acid. Using the expanded disability status scale (EDSS), the degree of impairment in sufferers with MS became assessed and fatigue became evaluated the usage of the fatigue severity scale (FSS). Results: Patients had significantly higher serum lactate levels when relative to controls (40.7 ± 18.1 versus 20. 1 ± 5.8 mg/dl, p=0.001). There were no statistically relevant variations among patients and controls regarding serum uric acid levels (4.9 ± 1.1 versus 5.3 ± 1.2 mg/dl, p=0.337). Correlation analysis showed significantly inverse correlation among levels of serum lactate and EDSS (r=-0.421, p=0.016) and FSS (r=-0.504, p=0.003). Conclusions: Serum lactate but not serum uric acid is elevated in MS patients. It was associated with EDSS and FSS.

Open-access reader

About this research paper

What this paper is about

Background and aim: It’s though that mitochondrial dysfunction is participated in multiple sclerosis (MS) pathogenesis. Serum lactate and uric acid levels are biochemical markers related to mitochondrial dysfunction. The present study aimed to assess mitochondrial dysfunction in sufferers with MS through investigating lactate and uric acid serum levels. Subjects and methods: This case manages observe turned into carried out on 32 patients with MS and 20 safe controls matched by age and sex. Patients have been diagnosed with MS in keeping with Revised McDonald Criteria. Both participants underwent a careful history taking, thorough general and neurological exam and evaluation of serum lactate and uric acid. Using the expanded disability status scale (EDSS), the degree of impairment in sufferers with MS became assessed and fatigue became evaluated the usage of the fatigue severity scale (FSS). Results: Patients had significantly higher serum lactate levels when relative to controls (40.7 ± 18.1 versus 20. 1 ± 5.8 mg/dl, p=0.001). There were no statistically relevant variations among patients and controls regarding serum uric acid levels (4.9 ± 1.1 versus 5.3 ± 1.2 mg/dl, p=0.337). Correlation analysis showed significantly inverse correlation among levels of serum lactate and EDSS (r=-0.421, p=0.016) and FSS (r=-0.504, p=0.003). Conclusions: Serum lactate but not serum uric acid is elevated in MS patients. It was associated with EDSS and FSS.

Why it matters

OpenAlex reports 2 citations for this work. Citation counts describe recorded attention and do not establish research quality.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Background and aim: It’s though that mitochondrial dysfunction is participated in multiple sclerosis (MS) pathogenesis. Serum lactate and uric acid levels are biochemical markers related to mitochondrial dysfunction. The present study aimed to assess mitochondrial dysfunction in sufferers with MS through investigating lactate and uric acid serum levels. Subjects and methods: This case manages observe turned into carried out on 32 patients with MS and 20 safe controls matched by age and sex. Patients have been diagnosed with MS in keeping with Revised McDonald Criteria. Both participants underwent a careful history taking, thorough general and neurological exam and evaluation of serum lactate and uric acid. Using the expanded disability status scale (EDSS), the degree of impairment in sufferers with MS became assessed and fatigue became evaluated the usage of the fatigue severity scale (FSS). Results: Patients had significantly higher serum lactate levels when relative to controls (40.7 ± 18.1 versus 20. 1 ± 5.8 mg/dl, p=0.001). There were no statistically relevant variations among patients and controls regarding serum uric acid levels (4.9 ± 1.1 versus 5.3 ± 1.2 mg/dl, p=0.337). Correlation analysis showed significantly inverse correlation among levels of serum lactate and EDSS (r=-0.421, p=0.016) and FSS (r=-0.504, p=0.003). Conclusions: Serum lactate but not serum uric acid is elevated in MS patients. It was associated with EDSS and FSS.

Key concepts: Multiple sclerosis, Medicine, Internal medicine, Psychology, Neuroscience, Psychiatry

Related papers

Back to paper searchBrowse research topicsOriginal source
Laboratory Evaluation for Mitochondrial Dysfunction in Multiple Sclerosis Patients — Research Paper | ScholarLens